This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Takara Bio USA – RetroNectin® GMP Grade Reagents

Closed

26-005759Federal

Submission Closed05/14/2026, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, SALMONELLAThe contract pertains to the procurement of a Salmonella test kit identified by NSN/Part Number 6550-01-360-5759, with a single unit requested under purchase request number 7017103971. The solicitation, numbered SPE2DS-26-T-143V, was issued by the Defense Logistics Agency under the Department of Defense and was posted on June 9, 2026. Interested parties were required to respond by June 15, 2026. The contract is a solicitation type with no specified set-aside type or NAICS code, indicating it is open to qualified suppliers without specific socioeconomic restrictions. The contract's place of performance and office address details are unspecified beyond being within the United States. This procurement is conducted under federal jurisdiction, specifically through the Defense Logistics Agency, which manages logistics and supply chain solutions for the Department of Defense. There is no contact information included for direct correspondence, but an online link to the solicitation is provided, enabling interested suppliers to access further details and submit responses.

Defense Logistics Agency

POSTED

DEADLINE

CULTURE MEDIUM, ANAEThe contract pertains to the procurement of a culture medium identified as ANAE, with the National Stock Number 6550-01-216-6875. It involves a purchase request for a quantity of one unit. This solicitation, numbered SPE2DS-26-T-155T, was issued by the Defense Logistics Agency under the Department of Defense and posted on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. The contract is classified as a federal solicitation, but there is no specified set-aside or NAICS code associated with it. The place of performance and specific office addresses remain unspecified. The contracting opportunity is accessible via the Defense Logistics Agency's online procurement system, indicating a formal and structured acquisition process for the required culture medium product.

Defense Logistics Agency

POSTED

DEADLINE

PHENOL RED PH TESTThe contract pertains to the procurement of three units of Phenol Red pH Test kits, identified by NSN 6550-01-095-6757. It was issued under solicitation number SPE2DS-26-T-152Z by the Defense Logistics Agency, a federal entity within the Department of Defense. The solicitation was posted on June 14, 2026, with a response deadline set for June 22, 2026. This procurement does not specify any set-aside designation or NAICS code and does not provide detailed location information for performance or point of contact. The contract aims to fulfill a requirement for these specific pH test kits for the Department of Defense through the Defense Logistics Agency’s solicitation process.

Defense Logistics Agency

POSTED

DEADLINE

REAGENT SET, ANTIBODThe contract pertains to the procurement of a reagent set for antibodies, identified by NSN/Part Number 6550-01-204-5368, with a quantity of one unit requested under purchase request number 7017121423. The solicitation, labeled SPE2DS-26-T-148Q, was posted by the Defense Logistics Agency of the Department of Defense on June 11, 2026, with responses due by June 17, 2026. This contract is a federal solicitation intended for suppliers to provide the specified reagent set, but does not indicate any set-aside type or specify the size or type of business preferred for submission. The contract details include limited information about the place of performance or specific office address, implying that these details may be provided upon award or through direct inquiry. The solicitation is managed by the Defense Logistics Agency, responsible for supplying materials across the Department of Defense. Interested parties can access the complete solicitation documents and respond via the provided DLA Bid System electronic portal, facilitating a competitive procurement process for this specialized reagent set.

Defense Logistics Agency

POSTED

DEADLINE

Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune DiseaseThis contract seeks the development of innovative, rapid diagnostic assays aimed at addressing the critical need for early and accurate detection of multi-system autoimmune diseases. The intended diagnostic tool would enable primary care physicians to identify and predict tissue-specific manifestations of autoimmune conditions, improving patient management by facilitating timely specialist referrals. This approach leverages recent advancements in technology that allow for the detection of immune-mediated tissue stress through analysis of circulating cells and tissue-specific molecular markers. The solicitation is a total small business set-aside under the Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) mandate, targeting companies with fewer than 500 employees. Issued by the Department of Health and Human Services through the ARPA-H agency, the contract emphasizes accelerating translational technologies that can be implemented in primary care settings. Responses to the solicitation are due by July 10, 2026, and interested parties are encouraged to explore the detailed requirements and submission guidelines on the official SBIR portal.

Arpa-H

POSTED

6 days ago

DEADLINE

in 23 days

AI Contract Overview

The National Institutes of Health (NIH) intends to award a sole source firm-fixed-price contract to Takara Bio USA Inc. for the supply of 15 vials of RetroNectin® GMP grade reagent, essential for the manufacturing of cellular therapy products at the NIH Clinical Center’s Center for Cellular Engineering (CCE). This reagent, produced exclusively by Takara Bio USA, supports over 50 intramural clinical trials and is critical to patient care. Due to the unique manufacturing source and the need for regulatory revalidation that would cause delays and risks if alternatives were pursued, the procurement is conducted under a single-source authority in accordance with federal regulations. This notice serves informational purposes only and is not a request for quotations. While the NIH will not issue a solicitation or request quotations, interested parties may submit capability statements demonstrating their ability to fulfill the requirement. These statements should include company information, technical capability, proof of original equipment manufacturer (OEM) authorization, and relevant past performance. Responses must be submitted electronically by May 14, 2026, to the designated contracting officer, Shasheshe Goolsby, at the NIH Office of Acquisitions and Logistics Management in Bethesda, Maryland. The government maintains sole discretion over whether to compete the requirement.

General Info

NIH awards sole source contract to Takara Bio for 15 vials of RetroNectin® GMP reagent.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

Contract Value

$24,601.2

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing View NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Awardee

TAKARA BIO USA, INC.View Profile

Award Issued Date

05/20/2026, 12:00:00 AM UTC

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 5

Presolicitation

Response DeadlineMay 14

Deadline has passed

Submission Closed

05/14/2026, 12:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Olao

Office AddressBETHESDA, MD, 20892, USA

Contacts

Shasheshe Goolsby

contact@example.gov

+1 (555) 000-0000

Full Description

Title:
Takara Bio USA – RetroNectin® GMP Grade Reagents

Product Service Code (PSC): 6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

NAICS Code: 325413 – In Vitro Diagnostic Substance Manufacturing

Place of Performance:
National Institutes of Health
Clinical Center
Bethesda, MD 20892

POTS: 26-005759

Description

This notice is issued for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued, and quotations will not be requested.

The National Institutes of Health (NIH), Clinical Center, intends to award a sole source firm-fixed-price contract to Takara Bio USA Inc. for the procurement of RetroNectin® GMP grade reagents.

The requirement consists of 15 vials of RetroNectin® GMP grade reagent (Product Code: T202), which are critical for the manufacturing of cellular therapy products within the Center for Cellular Engineering (CCE).

Background

The Center for Cellular Engineering (CCE) supports over 50 intramural clinical trials and manufactures cellular therapy products used in patient care.

Rationale:

Takara Bio USA Inc. is the sole manufacturer of RetroNectin® GMP grade reagent. Substitution is not permissible without revalidation and regulatory approval, which could delay treatment and pose risks to patient care

Authority

This acquisition is being conducted in accordance with:

FAR 13.106-1(b)(1) – Soliciting from a Single Source

Under this authority, the Contracting Officer may solicit from a single source when it is determined that only one source is reasonably available to meet the Government’s requirements.

Acquisitions conducted under FAR Part 13 – Simplified Acquisition Procedures are exempt from the competition requirements of FAR Part 6.

Responses

This is not a request for quotations. However, interested parties may submit a capability statement demonstrating their ability to meet the Government’s requirement.

Responses must include:

Company name and address
Technical capability
Proof of OEM authorization
Relevant past performance

The Government will evaluate capability statements received in response to this notice. The determination not to compete this requirement is solely within the discretion of the Government.

Submission Instructions

Responses referencing POTS: 26-005759 must be submitted electronically no later than May 14, 2026, at 8:00 AM EST to:

Shasheshe Goolsby
Team Leader
Hospital and Laboratory Support Division

Office of Acquisitions and Logistics Management
National Institutes of Health

Email: shasheshe.goolsby@nih.gov